Lista de obras - Michael Laffan - Dominio Público Uruguay

A Mendelian randomization of γ' and total fibrinogen levels on venous thromboembolism and ischemic stroke

artículo científico publicado en 2020

A comparison between the platelet activating properties of different contrast media used in radiology and MRI ⬇️

artículo científico publicado el 1 de agosto de 1997

Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47-58): use of direct acting oral anticoagulants

artículo científico publicado en 2020

Analysis and results of the recombinant factor VIIa extended-use registry ⬇️

artículo científico publicado el 1 de junio de 2003

Can you grow out of von Willebrand disease?

artículo científico publicado en 2017

Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials?

artículo científico publicado en 2020

Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg(2+) homeostasis and cytoskeletal architecture

artículo científico publicado en 2016

Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders

scientific article published on 01 December 2019

Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay

artículo científico publicado en 2018

Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding

artículo científico publicado en 2017

Genetically Determined FXI (Factor XI) Levels and Risk of Stroke

article

Genetically Determined Platelet Count and Risk of Cardiovascular Disease

artículo científico publicado en 2018

Germline mutations in the transcription factor IKZF5 cause thrombocytopenia

scientific article published on 01 December 2019

Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis

artículo científico publicado en 2020

Inherited platelet disorders: toward DNA-based diagnosis

artículo científico publicado en 2016

International Society on Thrombosis and Haemostasis core curriculum project: core competencies in clinical thrombosis and hemostasis

artículo científico publicado en 2015

Intracranial Hemorrhage and Early Mortality in Patients Receiving Extracorporeal Membrane Oxygenation for Severe Respiratory Failure.

artículo científico publicado en 2018

Limitations on point care APTT for monitoring of unfractionated heparin in intensive care patients

scientific article published on 01 August 2019

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A

artículo científico publicado en 2020

NICE NG89 recommendations for extended pharmacological thromboprophylaxis - is it justified and is it cost effective: a rebuttal from the British Society for Haematology

artículo científico publicado en 2019

New oral anticoagulants: should they replace heparins and warfarin?

artículo científico publicado el 1 de enero de 2011

New oral anticoagulants: their role and future

artículo científico publicado en 2013

Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin

scientific article published on 20 September 2019

Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms

artículo científico publicado en 2019

Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?

artículo científico publicado en 2014

Phenotype description and response to thrombopoietin receptor agonist in -related disorder

artículo científico publicado en 2018

Pregnancy in type 2B VWD: a case series ⬇️

artículo científico publicado el 14 de noviembre de 2011

Purified factor VIII ⬇️

artículo científico publicado el 19 de agosto de 1995

Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality

artículo científico publicado en 2014

Recommendations for the clinical interpretation of genetic variants and presentation of results to patients with inherited bleeding disorders. A UK Haemophilia Centre Doctors' Organisation Good Practice Paper

scientific article published on 01 January 2019

Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

artículo científico publicado en 2015

Site-specific analysis of von Willebrand factor O-glycosylation

artículo científico publicado en 2016

Specific treatment for cancer-associated thrombosis

artículo científico publicado en 2015

The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension

artículo científico publicado en 2019

The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology

artículo científico publicado en 2014

The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants

The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing

scientific article published on 11 April 2019

The heparin-von Willebrand factor interaction and conventional tests of haemostasis - the challenges in predicting bleeding in cardiopulmonary bypass

scientific article published on 05 December 2020

The top 10 research priorities in bleeding disorders: a James Lind Alliance Priority Setting Partnership

scientific article published on 23 April 2019

The use of viscoelastic haemostatic assays in the management of major bleeding: A British Society for Haematology Guideline

artículo científico publicado en 2018

Thrombolysis restores perfusion in COVID 19 hypoxia

scientific article published on 31 July 2020

Thrombophilia in non-thrombotic chronic venous disease of the lower limb - a systematic review

artículo científico publicado en 2018

Thrombophilia: an expanding group of genetic defects that predispose to thrombosis ⬇️

artículo científico publicado el 1 de julio de 1997

Use of Antithrombin Concentrate for Acquired Antithrombin Deficiency in Acutely Unwell Children Receiving Unfractionated Heparin

scientific article published on 21 October 2019

Utility of fibrinogen in the coagulation screen.

artículo científico publicado en 2019

Von Willebrand factor and angiogenesis: basic and applied issues

artículo científico publicado en 2016

announcement: Non‐malignant haematology research in the UK: looking forward to new opportunities ⬇️

artículo científico publicado el 1 de septiembre de 2010

von Willebrand disease: Diagnosis and treatment, treatment of women, and genomic approach to diagnosis

artículo científico publicado en 2020

Lista de obras de Michael Laffan

A Mendelian randomization of γ' and total fibrinogen levels on venous thromboembolism and ischemic stroke

A comparison between the platelet activating properties of different contrast media used in radiology and MRI ⬇️

Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47-58): use of direct acting oral anticoagulants

Analysis and results of the recombinant factor VIIa extended-use registry ⬇️

Can you grow out of von Willebrand disease?

Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials?

Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg(2+) homeostasis and cytoskeletal architecture

Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders

Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay

Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding

Genetically Determined FXI (Factor XI) Levels and Risk of Stroke

Genetically Determined Platelet Count and Risk of Cardiovascular Disease

Germline mutations in the transcription factor IKZF5 cause thrombocytopenia

Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis

Inherited platelet disorders: toward DNA-based diagnosis

International Society on Thrombosis and Haemostasis core curriculum project: core competencies in clinical thrombosis and hemostasis

Intracranial Hemorrhage and Early Mortality in Patients Receiving Extracorporeal Membrane Oxygenation for Severe Respiratory Failure.

Limitations on point care APTT for monitoring of unfractionated heparin in intensive care patients

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A

NICE NG89 recommendations for extended pharmacological thromboprophylaxis - is it justified and is it cost effective: a rebuttal from the British Society for Haematology

New oral anticoagulants: should they replace heparins and warfarin?

New oral anticoagulants: their role and future

Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin

Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms

Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?

Phenotype description and response to thrombopoietin receptor agonist in -related disorder

Pregnancy in type 2B VWD: a case series ⬇️

Purified factor VIII ⬇️

Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality

Recommendations for the clinical interpretation of genetic variants and presentation of results to patients with inherited bleeding disorders. A UK Haemophilia Centre Doctors' Organisation Good Practice Paper

Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Site-specific analysis of von Willebrand factor O-glycosylation

Specific treatment for cancer-associated thrombosis

The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension

The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology

The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants

The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing

The heparin-von Willebrand factor interaction and conventional tests of haemostasis - the challenges in predicting bleeding in cardiopulmonary bypass

The top 10 research priorities in bleeding disorders: a James Lind Alliance Priority Setting Partnership

The use of viscoelastic haemostatic assays in the management of major bleeding: A British Society for Haematology Guideline

Thrombolysis restores perfusion in COVID 19 hypoxia

Thrombophilia in non-thrombotic chronic venous disease of the lower limb - a systematic review

Thrombophilia: an expanding group of genetic defects that predispose to thrombosis ⬇️

Use of Antithrombin Concentrate for Acquired Antithrombin Deficiency in Acutely Unwell Children Receiving Unfractionated Heparin

Utility of fibrinogen in the coagulation screen.

Von Willebrand factor and angiogenesis: basic and applied issues

announcement: Non‐malignant haematology research in the UK: looking forward to new opportunities ⬇️

von Willebrand disease: Diagnosis and treatment, treatment of women, and genomic approach to diagnosis